HUTCHMED (China) Limited - stock earnings
HCM Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | 84.3 million USD | 266.4 million USD |
| 2023Q1 | 84.3 million USD | 266.4 million USD |
| 2022Q4 | -99.0 million USD | 112.2 million USD |
| 2022Q3 | -99.0 million USD | 112.2 million USD |
| 2022Q2 | -81.4 million USD | 101.0 million USD |
| 2022Q1 | -81.4 million USD | 101.0 million USD |
| 2021Q4 | -26.6 million USD | 138.2 million USD |
| 2021Q3 | -46.1 million USD | 99.4 million USD |
| 2021Q2 | -77.5 million USD | 75.8 million USD |
| 2021Q1 | -77.5 million USD | 75.8 million USD |
| 2020Q4 | -38.0 million USD | 60.6 million USD |
| 2020Q3 | -38.0 million USD | 60.6 million USD |
| 2020Q2 | -33.6 million USD | 55.2 million USD |
| 2020Q1 | -16.1 million USD | 51.6 million USD |
| 2019Q4 | -37.3 million USD | 52.8 million USD |
| 2019Q3 | -31.1 million USD | 49.3 million USD |
| 2019Q2 | -25.5 million USD | 50.0 million USD |
| 2019Q1 | -25.5 million USD | 50.0 million USD |
| 2018Q4 | -19.9 million USD | 52.2 million USD |
| 2018Q3 | -25.6 million USD | 58.8 million USD |
| 2018Q2 | -21.0 million USD | 49.9 million USD |
| 2018Q1 | -11.7 million USD | 52.3 million USD |
| 2017Q4 | -11.7 million USD | 52.3 million USD |
| 2017Q3 | -15.9 million USD | 69.3 million USD |
| 2017Q2 | 1.7 million USD | 126.6 million USD |
| 2017Q1 | 841000 USD | 63.3 million USD |
| 2016Q4 | 11.2 million USD | 111.6 million USD |
| 2016Q3 | -13.0 million USD | 121.9 million USD |
| 2016Q2 | 537000 USD | 104.5 million USD |
| 2015Q4 | 3.4 million USD | 56.3 million USD |
| 2015Q3 | 2.3 million USD | 56.2 million USD |
| 2015Q2 | 15.9 million USD | 82.5 million USD |
| 2014Q4 | 9.8 million USD | 33.6 million USD |
| 2014Q3 | -10.9 million USD | 27.9 million USD |
| 2013Q4 | 23.9 million USD | 36.5 million USD |
HCM Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 100.8 million USD | 838.0 million USD |
| 2022 | -410.1 million USD | 426.4 million USD |
| 2021 | -227.7 million USD | 356.1 million USD |
| 2020 | -194.6 million USD | 228.0 million USD |
| 2019 | -144.4 million USD | 204.9 million USD |
| 2018 | -74.8 million USD | 214.1 million USD |
| 2017 | -26.7 million USD | 241.2 million USD |
| 2016 | 11.7 million USD | 216.1 million USD |
| 2015 | 8.0 million USD | 178.2 million USD |
| 2014 | 5.4 million USD | 91.8 million USD |
| 2013 | 5.9 million USD | 46.0 million USD |
| 2012 | 3.6 million USD | 195.4 million USD |
| 2011 | 710223 USD | 166.9 million USD |
| 2010 | -6.9 million USD | 134.5 million USD |
| 2009 | -8.7 million USD | 111.0 million USD |
| 2008 | -17.8 million USD | 87.0 million USD |
| 2007 | -17.2 million USD | 65.1 million USD |
| 2006 | -9.6 million USD | 50.4 million USD |
| 2005 | -6.8 million USD | 37.9 million USD |
HCM
Price: $19.15
52 week price:
Earnings Per Share: 0.60 USD
P/E Ratio: -54.68
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 680726
Market Capitalization: 3.3 billion